News

Multimedia

Conferences

Publications

Brand Insights

Resources

Sustainability
DE&I
Pandemic
Finance
Legal
Technology
Regulatory
Global
Pricing
Strategy
R&D/Clinical Trials
Opinion
Executive Roundtable
Sales & Marketing
Executive Profiles
Leadership
Market Access
Patient Engagement
Supply Chain
Industry Trends

New Global Head of Development for Daiichi Sankyo

September 7, 2016

Article

September 7, 2016

Daiichi Sankyo, Inc. (Edison,NJ) announced the appointment of Marielle Cohard-Radice, M.D., as Executive Vice President, Global Head of Development.

In her new role, Dr. Cohard-Radice will have responsibility for the development strategy and portfolio planning for the Cardiovascular-Metabolism and Internal Medicine therapeutic areas.

Prior to her promotion, Marielle Cohard-Radice was Vice President of Clinical Development Operations at Daiichi Sankyo Pharma Development, a position she held since 2012.

The former Global Head of Development, Mahmoud Ghazzi, M.D., Ph.D, has decided to leave the company.

Related Content

AI in Pharma: Where, When, and How Executives are Considering it

Gaugarin Oliver

November 19th 2024

Article

As skepticism surrounding AI fades, pharma industry execs are ready to embrace the technology.

Drilling in on Disease Hallmarks: New Tricks to Solve Age-Old Problems

Mike Hollan

November 15th 2024

Article

Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, discusses how AI is being used to find new ways to treat age-related conditions.

The Leap Forward: Practical Gains for Pharma AI Use

Bianca Anghelina;Helen Merianos;Ruth Beadle

November 14th 2024

Article

Exploring those areas and functions where the application of generative artificial intelligence—through use cases borne out in practice—are demonstrating tangible value and driving life sciences innovation to new heights.